Skip to main content

Table 2 Antimicrobial prescriptions in 2016 and 2018 for cases with aURTDa, FLUTDb and abscesses

From: Antimicrobial prescriptions in cats in Switzerland before and after the introduction of an online antimicrobial stewardship tool

Parameter aURTDa FLUTDb Abscesses
  2016 2018 2016 2018 2016 2018
Total number of cases n = 227 n = 244 n = 333 n = 324 n = 216 n = 224
  % [CI]c % [CI]c % [CI]c % [CI]c % [CI]c % [CI]c
Antimicrobial treatment Yesd 77.1 [71.1–82.4] 67.6 [61.4–73.5] 60.1 [54.6–65.4] 48.8 [43.2–54.4] 95.8 [92.2–98.1] 91.5 [87.1–94.8]
Details of antimicrobial treatment n = 175 n = 165 n = 200 n = 158 n = 207 n = 205
  % [CI]c % [CI]c % [CI]c % [CI]c % [CI]c % [CI]c
Potentiated aminopenicillin 40.0 [32.7–47.7] 49.1 [41.2–57.0] 60.5 [53.4–67.3] 69.6 [61.8–76.7] 63.8 [56.8–70.3] 63.4 [56.4–70.0]
3rd generation cephalosporin 28.0 [21.5–35.3] 23.6 [17.4–30.9] 25.5 [19.6–32.1] 13.9 [8.9–20.3] 25.1 [19.4–31.6] 20.5 [15.2–26.7]
Aminopenicillin 23.4 [17.4–30.4] 29.1 [22.3–36.7] 11.5 [7.4–16.8] 20.9 [14.8–28.1] 24.2 [18.5–30.6] 32.2 [25.9–39.1]
Fluoroquinolone 4.0 [1.6–8.1] 8.5 [4.7–13.8] 12.5 [8.3–17.9] 15.8 [10.5–22.5] 2.4 [0.8–5.5] 3.4 [1.4–6.9]
Tetracycline 16.0 [10.9–22.3] 20.6 [14.7–27.6] 0.5 [0.0–2.8] 0.0 [0.0–2.3] 0.0 [0.0–1.8] 0.5 [0.0–2.7]
1st generation cephalosporin 0.6 [0.0–3.1] 0.0 [0.0–2.2] 3.0 [1.1–6.4] 1.3 [0.2–4.5] 5.8 [3.0–9.9] 9.3 [5.7–14.1]
Otherse 4.0 [1.6–8.1] 3.6 [1.3–7.7] 0.5 [0.0–2.8] 0.0 [0.0–2.3] 2.4 [0.8–5.5] 3.9 [1.7–7.5]
HPCIAsf Yesd 33.7 [26.8–41.2] 33.9 [26.8–41.7] 38.0 [31.2–45.1] 29.7 [22.7–37.5] 27.5 [21.6–34.2] 23.9 [18.2–30.3]
Serial/combination therapy Yesd 14.3 [9.5–20.4] 30.3 [23.4–37.9] 13.0 [8.7–18.5] 19.6 [13.7–26.7] 23.2 [17.6–29.5] 31.7 [25.4–38.6]
Treatment duration (days)g   n = 140 n = 127 n = 178 n = 134 n = 153 n = 164
   Median (range) Median (range) Median (range) Median (range) Median (range) Median (range)
  12 (4–37) 10 (1–21) 13 (1–56)h 9.5 (1–42)h 9 (1–28) 9 (2–28)
  1. Non-overlapping 95% confidence intervals or comparisons with p-values < 0.05 (for treatment duration) are shown in bold; Data from cases from 2016 has been published previously [45]; aaURTD, acute upper respiratory tract disease; bFLUTD, feline lower urinary tract disease; cCI, 95% confidence interval; dValues for the category “no” (reference group) are not shown; eOthers (antimicrobial classes used in ≤ 2% of prescriptions) included amphenicoles, lincosamides, macrolides, penicillins, nitroimidazoles; fHPCIAs, highest priority critically important antimicrobials; gTreatment duration was unknown for numbers not listed (2016: n = 111; 2018: n = 103); hp-value = 0.006